ImageneBio Inc
IMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $775,990 | $741,245 | $949,720 |
| - Cash | $103,162 | $58,290 | $36,763 | $39,393 |
| + Debt | $8,794 | $5,677 | $6,610 | $7,521 |
| Enterprise Value | – | $723,377 | $711,092 | $917,848 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$45 | -$3,715 | -$4,580 |
| % Margin | – | – | – | – |
| EBITDA | -$24,757 | -$8,354 | -$9,272 | -$12,086 |
| % Margin | – | – | – | – |
| Net Income | -$24,779 | -$2,767 | -$8,619 | -$9,124 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.005 | -0.057 | -0.18 | -0.19 |
| % Growth | -5,144.7% | 68.2% | 5.3% | – |
| Operating Cash Flow | -$26,642 | -$3,422 | -$10,562 | -$6,260 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$26,642 | -$3,422 | -$10,562 | -$6,260 |